Want to see FLNA full AI Analyst Report?
Filana Therapeutics (FLNA) Hedge Fund Trading Activity
Trend: â–¼ Hedge Funds Decreased Holdings by 51.2K Shares Last Quarter
Hedge Fund Holdings in FLNA
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity​
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 BlackRock, Inc. | Not Ranked | Added | 2.76% | $1,729,738 | <0.01% | ||
 Thomas E. Claugus | GMT Capital Corp | Not Changed | 0.00% | $535,619 | 0.03% | ||
| Drew Phillips | Fortitude Family Office, LLC | Not Changed | 0.00% | $402 | <0.01% | ||
 Kenneth Tropin | Graham Capital Management, L.P. | Sold Out | -100.00% | $0 | 0.00% | ||
| Colin Cox | Gallacher Capital Management LLC | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Filana Therapeutics?
The hedge funds that hold the most shares in Filana Therapeutics are Kenneth Tropin, Thomas E. Claugus and BlackRock, Inc..
Are hedge funds buying or selling FLNA?
In the last quarter hedge funds have Decreased their holdings in Filana Therapeutics by 51.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Filana Therapeutics stock?
Warren Buffet currently does not own shares in Filana Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
